PRODRUG DESIGN

[1] CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J]. NATURE, 1958, 182 (4633) : 421 - 423

[2] ALBERT A, 1964, SELECTIVE TOXICITY

[3] ARIENS EJ, 1971, DRUG DESIGN, V1, P2

[4] PLASMA CONCENTRATIONS AND EXCRETION OF MECILLINAM AFTER ORAL-ADMINISTRATION OF PIVMECILLINAM IN ELDERLY PATIENTS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (03) : 241 - 246

[5] BACAMPICILLIN - NEW ORALLY WELL-ABSORBED DERIVATIVE OF AMPICILLIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (05) : 518 - 525

[6] BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P67

[7] BUNDGAARD H, 1976, ACTA PHARM SUEC, V13, P9

[8] BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P47

[9] Butler K, 1971, Del Med J, V43, P366

[10] CRITICAL ANALYSIS OF FLIP-FLOP PHENOMENON IN 2-COMPARTMENT PHARMACOKINETIC MODEL [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (08) : 1140 - 1144

[1] CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J]. NATURE, 1958, 182 (4633) : 421 - 423

[2] ALBERT A, 1964, SELECTIVE TOXICITY

[3] ARIENS EJ, 1971, DRUG DESIGN, V1, P2

[4] PLASMA CONCENTRATIONS AND EXCRETION OF MECILLINAM AFTER ORAL-ADMINISTRATION OF PIVMECILLINAM IN ELDERLY PATIENTS [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (03) : 241 - 246

[5] BACAMPICILLIN - NEW ORALLY WELL-ABSORBED DERIVATIVE OF AMPICILLIN [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (05) : 518 - 525

[6] BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P67

[7] BUNDGAARD H, 1976, ACTA PHARM SUEC, V13, P9

[8] BUNDGAARD H, 1977, ACTA PHARM SUEC, V14, P47

[9] Butler K, 1971, Del Med J, V43, P366

[10] CRITICAL ANALYSIS OF FLIP-FLOP PHENOMENON IN 2-COMPARTMENT PHARMACOKINETIC MODEL [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (08) : 1140 - 1144